Soudabeh Hosseini

Dr. Soudabeh Hosseini

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
ATAzita Tavasoli
Azita Tavasoli
KRKhadije Arjmandi Rafsanjani
Khadije Arjmandi Rafsanjani
SHSaba Hemmati
Saba Hemmati
MMMarziyeh Mojbafan
Marziyeh Mojbafan
EZElham Zarei
Elham Zarei
SHSoudabeh Hosseini
Soudabeh Hosseini
Manganese is a critical trace element that not only has antioxidant properties, but also is essential for various metabolic pathways and neurotransmitters production. However, it can be toxic at high levels, particularly in the central nervous system. Manganese intoxication can be acquired, but an inherited form due to autosomal-recessive mutations in the SLC30A10 gene encoding a Mn transporter protein has also been reported recently. These mutations are associated with significant failure of manganese excretion and its storage in the liver, brain (especially basal ganglia), and other peripheral tissues, resulting in toxicity. A 10-year-old boy from consanguineous parents presented with a history of progressive truncal instability, gait difficulty, and frequent falls for 2 months. He had dystonia, rigidity, ataxia, dysarthria, bradykinesia and a plethoric skin. Investigations showed polycythemia, low serum iron and ferritin levels, and increased total iron binding capacity. A brain MRI revealed symmetric hyperintensities in the basal ganglia and dentate nucleuses on TI images that were suggestive of brain metal deposition together with clinical manifestations. Serum calcium and copper levels were normal, while the manganese level was significantly higher than normal values. There was no history of environmental overexposure to manganese. Genetic testing showed a homozygous missense mutation in SLC30A10 (c.C1006T, p.His336Tyr) and Sanger sequencing confirmed a homozygous state in the proband and a heterozygous state in the parents. Regular treatment with monthly infusions of disodium calcium edetate and oral iron compounds resulted in decreased serum manganese and hemoglobin levels to normal values, significant resolution of MRI lesions, and partial improvement of neurological symptoms during 6 months of follow-up. The syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by SLC30A10 mutation is a treatable inherited metal deposition syndrome. The patient may only have pure neurological without hepatic manifestations. Although this is a rare and potentially fatal inborn error of metabolism, early diagnosis and continuous chelation therapy might improve the symptoms and prevent disease progression.

10 November 2015 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
SHSoudabeh Hosseini
Soudabeh Hosseini
EKEbrahim Kalantar
Ebrahim Kalantar
MHMaryam Sadat Hosseini
Maryam Sadat Hosseini
STShadi Tabibian
Shadi Tabibian
MSMorteza of Shamsizadeh
Morteza of Shamsizadeh
Akbar DorgalalehAkbar Dorgalaleh
Akbar Dorgalaleh
Venous thromboembolism (VTE) could be manifested as deep venous thrombosis (DVT) or pulmonary embolism (PE). DVT is usually the more common manifestation and is usually formation of a thrombus in the deep veins of lower extremities. DVT could occur without known underlying cause (idiopathic thrombosis) which could be a consequence of an inherited underlying risk factor or could be a consequence of provoking events, such as trauma, surgery or acute illness (provoked thrombosis). Our aim in this study was to assess the impact of some previously reported genetic risk factors including, methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C, plasminogen activator inhibitor-1(PAI-1) 4G/5G, prothrombin 20210 and FV Leiden on occurrence of DVT in a population of Iranian patients. This long-term study was conducted on 182 patients with DVT and also 250 age and sex matched healthy subjects as control group. The diagnosis of DVT was based on patient’s history, clinical findings, D-dimer test, and confirmed by Doppler ultrasonography. After confirmation of DVT, both groups were assessed for the five mentioned mutations. The relationship between mutations and predisposition to DVT was calculated by using logistic regression and expressed as an OR with a 95 % confidence interval (CI). Our results revealed that FV Leiden (OR 6.7; 95 % CI = 2.2 to 20.3; P = 0.001), MTHFR C677T (OR 6.0; 95 % CI = 2.2 to 16.4; P < 0.001), MTHFR A1298C (OR 8.3; 95 % CI = 4.4 to 15.8; P < 0.001), and PAI-1 4G/5G (OR 3.8; 95 % CI = 2.1 to 7.2; P < 0.001) mutations were all significantly associated with an increased risk of DVT. Prothrombin 20210 was found in none of the patients and controls. Our findings suggest that genetic risk factors have a contributory role on occurrence of DVT.

17 November 2024 in Clinical Case Reports
Verified
Journal Article
Open access
AEAziz Eghbali
Aziz Eghbali
SSSeyed Mehrab Safdari
Seyed Mehrab Safdari
MRMaedeh Yousefi Roozbahani
Maedeh Yousefi Roozbahani
KTKhatereh Tavajohi
Khatereh Tavajohi
SHSoudabeh Hosseini
Soudabeh Hosseini
Fanconi anemia (FA) is a rare inherited disorder characterized by congenital abnormalities, progressive bone marrow failure, and a predisposition to malignancies. Detecting FA can be challenging, as it involves identifying increased chromosomal sensitivity to DNA cross‐linking agents and detecting causative genetic variants via genome sequencing. We report two cases of siblings with FA, both confirmed to have the FANCD2 variant through whole‐exome sequencing (WES). The first patient presented with epistaxis, petechiae, ecchymosis, and lower limb edema. The second patient exhibited epistaxis, diabetes, developmental delay, and physical abnormalities. Interestingly, both patients had negative results on the initial chromosomal breakage test with mitomycin C, a commonly used diagnostic tool for FA. However, further investigation with WES revealed the presence of the FANCD2 variant, confirming the FA diagnosis. This case report highlights the challenges in diagnosing FA, particularly when initial screening tests yield negative results. Molecular genetic testing, such as WES, can provide a definitive diagnosis and guide appropriate management strategies. Early and accurate diagnosis is crucial for improving outcomes in individuals with this potentially fatal illness, as promising advancements in treatments such as hematopoietic stem cell transplantation and gene therapy offer hope for addressing FA.

22 April 2014 in Central European Journal of Immunology
Verified
Journal Article
Open access
SHSoudabeh Hosseini
Soudabeh Hosseini
KEKalantar Ebrahim
Kalantar Ebrahim
HNHooman Nakisa
Hooman Nakisa
Akbar DorgalalehAkbar Dorgalaleh
Akbar Dorgalaleh
HRHosseini Shamsabadi Rozita
Hosseini Shamsabadi Rozita
TBTaregh Bamedi
Taregh Bamedi
Background: Atypical hemolytic uremic syndrome (aHUS), a rare disorder characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure, is associated with mutations and polymorphisms in various components and regulators of the complement alternative pathway (AP), including factor H, factor I, membrane cofactor protein (MCP or CD46) and factor B. This impaired regulation of the alternative pathway leads to a procoagulant state with microthrombi formation in the renal vasculature, which influences disease onset and progression. Aim of the study: To evaluate the role of complement regulatory factors in occurrence of aHUS; we also included evaluation of ADAMTS13 activity and autoantibody against ADAMTS13 in order to exclude thrombotic thrombocytopenic purpura (TTP) cases, which might have overlapping clinical and laboratory findings. Material and methods: This study was conducted on 273 individuals with aHUS. Diagnosis was based on clinical manifestations, kidney function tests, red blood cell count, morphology and reticulocyte count. Then, the ADAMTS13 autoantibody and activity and also complement factor B, complement factor H (CFH) and complement factor-I (CIF) were analyzed. Finally, the statistical analysis was performed by SPSS software. Results: The mean age of our patients was 27.3 years, 55% were female and 45% were male. The mean levels of urea and creatinine concentration were 92.9 mg/dl and 5.1 mg/dl, respectively. The mean levels of RBC count, Hb and HCT in these patients were lower than normal but the mean percentage of reticulocyte count was higher than normal (2.5%). The assessment of complement regulatory factors revealed that the B and H factors levels were normal except in two cases but the level of factor I was higher than normal. Conclusions: According to the results of this study, it seems that up regulation of factor I had a significant role in occurrence of aHUS in our study group.

21 September 2011 in Case Reports in Hematology
Verified
Journal Article
Open access
SHSoudabeh Hosseini
Soudabeh Hosseini
GBG. H. Bahoush
G. H. Bahoush
PVP. Vousogh
P. Vousogh
SASh. Ansari
Sh. Ansari
KAKh. Arjmandi
Kh. Arjmandi
MSM. Sabzechian
M. Sabzechian
We report a girl with a history of Ph(−) pre-B-ALL and three years of disease-free survival admitting to our hospital for regular end of treatment checkup with an increased white blood cell count which in follow-up studies and molecular detection of BCR-ABL (p210) fusions gene had been diagnosed as a Ph(+) typical CML. The upcoming question in this case scenario is whether developed CML is a secondary leukemia due to previous ALL chemotherapy or just a relapse case of primary leukemia.

27 May 2025 in Haemophilia
Verified
Journal Article
Closed access
SSSeyed Mehrab Safdari
Seyed Mehrab Safdari
MBMahmood Barati
Mahmood Barati
SHSoudabeh Hosseini
Soudabeh Hosseini
EKEbrahim Kalantar
Ebrahim Kalantar
FZFarhad Zaker
Farhad Zaker
Akbar DorgalalehAkbar Dorgalaleh
Akbar Dorgalaleh